Education
About Us
Working with TipRanks
Follow Us
Leafly Holdings (LFLYD)
OTHER OTC:LFLYD
Top Page
Leafly Holdings
(OTC:LFLYD)
Select Model
Select Model
Rating:38Underperform
Price Target:
$35.00
▼(-5.41% Downside)
Leafly Holdings' overall stock score is primarily impacted by its weak financial performance and bearish technical indicators. The company's high leverage, negative equity, and lack of profitability are significant concerns. Additionally, the stock's technical analysis indicates weak market sentiment, further contributing to the low score. The absence of earnings call data and corporate events does not alter the overall assessment.
Leafly Holdings (LFLYD) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$232.18K
Dividend YieldN/A
Average Volume (3M)87.00
Price to Earnings (P/E)―
Beta (1Y)-1.67
Revenue Growth-16.42%
EPS Growth39.35%
CountryUS
Employees110
SectorCommunication Services
Sector Strength97
IndustryMedical - Pharmaceuticals
Share Statistics
EPS (TTM)N/A
Shares Outstanding6,275
10 Day Avg. Volume68
30 Day Avg. Volume87
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$35.00Price Target Upside-5.41% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering0
Leafly Holdings Business Overview & Revenue Model
Company DescriptionLeafly Holdings, Inc. owns and operates a platform to provide consumers with cannabis information and connects consumers to cannabis brands and licensed retailers. It offers subscription-based marketplace listings, digital advertising solutions, and software as a service-based tools to cannabis retailers and brands; and information, reviews, menus, and ordering and delivery options to its audience through its website and mobile applications. The company was founded in 2010 and is headquartered in Seattle, Washington.
How the Company Makes MoneyLeafly Holdings generates revenue primarily through advertising and subscription services. The company offers advertising solutions to cannabis brands and dispensaries seeking to reach a targeted audience on its platform. This includes display ads, sponsored content, and promoted listings that enhance visibility and engagement. Additionally, Leafly sells subscription packages to dispensaries and cannabis businesses, providing them with enhanced profile features, analytics, and customer engagement tools. These services are designed to help businesses improve their market presence and connect with potential customers. Significant partnerships with cannabis industry stakeholders and a vast database of reviews and information further contribute to Leafly's earnings by attracting a large user base, which in turn drives advertising demand.
Leafly Holdings Earnings Call Summary
Earnings Call Date:―
(Q2-2024)
| Next Earnings Date:―
Earnings Call Sentiment Neutral
While Leafly achieved a positive adjusted EBITDA and made strategic expansions, significant revenue declines, retail account reductions, and ongoing payment delinquencies present notable challenges. The positive aspects are countered by financial and operational hurdles.Q2-2024 Updates
Positive Updates
Positive Adjusted EBITDA
Leafly reported a positive adjusted EBITDA of $483,000 for Q2, reflecting continued focus on profitability despite muted revenue performance.
Improved Gross Margin
Gross margin improved to 89% in Q2 compared to 88% in the same quarter last year.
Ohio Recreational Program Launch
Leafly sees strong momentum with the early launch of Ohio's recreational cannabis program, with projected annual sales reaching $2.8 billion by 2030.
Expansion with Uber Eats in Alberta
Leafly expanded its partnership with Uber Eats in Alberta, Canada, enabling legal cannabis delivery directly to consumers' homes.
Negative Updates
Revenue Decline
Leafly reported a Q2 revenue of $8.7 million, down 18.3% year-over-year and 3.6% sequentially.
Retail Account Reduction
The number of retail accounts decreased to 3,595, a decline of 245 accounts compared to the previous quarter, with significant declines in Florida, California, and Oklahoma.
Brand Revenue Drop
Brand revenue was $1.4 million, down 25% year-over-year, although it increased from $1.2 million in Q1.
Payment Delinquencies
Payment delinquencies accounted for nearly 40% of the monthly recurring revenue lost in the quarter, reflecting broader industry capital challenges.
Company Guidance
During the Leafly Q2 2024 earnings call, the company provided guidance for the third quarter, projecting revenue of around $8.4 million and an adjusted EBITDA loss of less than $1 million. For Q2, Leafly reported revenue of $8.7 million, a net loss of $1.3 million, and a positive adjusted EBITDA of $483,000, surpassing guidance. The company highlighted a 6.4% reduction in retail accounts, ending the quarter with 3,595 accounts, and noted that payment delinquencies accounted for nearly 40% of the monthly recurring revenue lost. Despite a 25% year-over-year decline in brand revenue to $1.4 million, there was an observed increase from Q1, attributed to seasonal spending around the 420 holiday. Leafly also reported improvements in gross margin, which stood at 89%, and a decrease in operating expenses, down 17.5% year-over-year. The company continues to focus on operational efficiency and stabilizing revenues while expressing optimism about ongoing projects and market opportunities in regions like Ohio and Washington, D.C.Leafly Holdings Financial Statement Overview
Summary
Income Statement
45
Neutral
Balance Sheet
30
Negative
Cash Flow
40
Negative
| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Leafly Holdings Technical Analysis
Negative
37.00
Price Trends
81.20
Negative
92.00
Negative
164.02
Negative
Market Momentum
-14.29
Negative
34.78
Neutral
<0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For LFLYD, the sentiment is Negative. The current price of 37 is below the 20-day moving average (MA) of 45.73, below the 50-day MA of 81.20, and below the 200-day MA of 164.02, indicating a bearish trend. The MACD of -14.29 indicates Negative momentum. The RSI at 34.78 is Neutral, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for LFLYD.
Leafly Holdings Risk Analysis
Leafly Holdings disclosed 90 risk factors in its most recent earnings report. Leafly Holdings reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 2 New Risks
1.
Our shares of common stock are listed on Nasdaq, but we cannot guarantee that we will be able to satisfy the continued listing standards going forward. Q3, 2022
2.
If we are unable to execute cost-cutting measures successfully, our total operating costs may be greater than expected, which would adversely affect our profitability. Q3, 2022
Leafly Holdings Peers Comparison
UnderperformOutperform
Sector (60)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
47 Neutral | $36.13M | ― | -321.37% | ― | 4455.07% | 77.31% | |
45 Neutral | $4.96M | ― | -248.95% | ― | ― | 98.45% | |
39 Underperform | $13.19M | ― | -33.13% | ― | -7.80% | 90.17% | |
38 Underperform | $232.18K | ― | ― | ― | -16.42% | 39.35% | |
29 Underperform | $3.20M | ― | -96.69% | ― | ― | 98.25% |
* Communication Services Sector Average
LFLYD
Leafly Holdings
37.00
-938.00
-96.21%
YCBD
cbdMD
1.43
-2.13
-59.83%
EVAX
Evaxion Biotech
6.29
-6.86
-52.17%
GRI
GRI Bio
1.91
-4.60
-70.66%
OCEA
Ocean Biomedical
0.01
-0.90
-98.90%
BJDX
Bluejay Diagnostics
1.87
-4.03
-68.31%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.